NCT05982249 Hypnosis and Virtual Reality in Bone Marrow Examination
| NCT ID | NCT05982249 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Bnai Zion Medical Center |
| Condition | Hematologic Diseases |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2023-07-13 |
| Primary Completion | 2026-07 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2023-07-13 with a primary completion date of 2026-07.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to compare the effects of hypnosis, virtual reality or their combination in patients undergoing a bone marrow procedure. The main question it aims to answer is whether such interventions may relieve anxiety and other symptoms described by patients undergoing the procedure. Before the bone marrow procedure and after being explained on the study and signing informed consent, the nurse will measure vital signs and participants will fill-out a 2-minutes' questionnaire and will be assigned to one of 3 groups: * Hearing a 7-minutes hypnotic script via earphones * Seeing and hearing virtual images and sounds via a virtual reality device during 7 minutes * None of these After these interventions or 10 minutes after assignation for patients not receiving intervention, patients will fill questionnaires again (about 5 minutes for filling the 2 questionnaires) and vital signs will be measured again. Then the bone marrow procedure will be performed. After the bone marrow procedure, the participants will fill-out another 2-minutes questionnaire and vital signs will be measured by the nurse. Researchers will compare hypnotic script, virtual reality, their combination or none of them to see if they can affect anxiety and other complaints in patients undergoing a bone marrow procedure.
Eligibility Criteria
Inclusion Criteria: 1. Age 18 or older 2. Candidate for a BM examination at the hematology unit 3. Ability to answer questionnaires in Hebrew, Arabic or Russian 4. Informed consent form signing Exclusion Criteria: 1. Major hearing impairment 2. Major visual impairment.
Contact & Investigator
Ilana Levy Yurkovski, MD
PRINCIPAL INVESTIGATOR
Bnai Zion Medical Center
Frequently Asked Questions
Who can join the NCT05982249 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Hematologic Diseases. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05982249 currently recruiting?
Yes, NCT05982249 is actively recruiting participants. Contact the research team at dana.weizer@b-zion.org.il for enrollment information.
Where is the NCT05982249 trial being conducted?
This trial is being conducted at Haifa, Israel.
Who is sponsoring the NCT05982249 clinical trial?
NCT05982249 is sponsored by Bnai Zion Medical Center. The principal investigator is Ilana Levy Yurkovski, MD at Bnai Zion Medical Center. The trial plans to enroll 100 participants.